Hot Features
プレミアム
Alkermes PLC (ALKS)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 166.69k | Automatic Disposition | 41.67 | 77.39k | -4.91% |
| 2026-06-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 111.66k | Derivative Exercise and Sale | 19.34 - 41.67 | 77.39k | - |
| 2026-05-29 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -16.22k | 371.03k | Derivative Exercise and Sale | 19.34 - 42.36 | 7.72k | - |
| 2026-05-21 | Dr. Christopher I. WrightIndependent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 27.68k | 20.28% |
| 2026-05-21 | Dr. Christopher I. WrightIndependent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 27.68k | - |
| 2026-05-21 | Mr. Frank Anders WilsonLead Independent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 35.75k | 15.01% |
| 2026-05-21 | Mr. Frank Anders WilsonLead Independent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 35.75k | - |
| 2026-05-21 | Dr. Nancy L. SnydermanIndependent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 36.18k | 14.81% |
| 2026-05-21 | Dr. Nancy L. SnydermanIndependent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 36.18k | - |
| 2026-05-21 | Mr. Brian P. McKeonIndependent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 48.54k | 10.64% |
| 2026-05-21 | Mr. Brian P. McKeonIndependent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 48.54k | - |
| 2026-05-21 | Ms. Nancy S. LurkerIndependent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 18.22k | 34.43% |
| 2026-05-21 | Ms. Nancy S. LurkerIndependent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 18.22k | - |
| 2026-05-21 | Dr. Cato T. LaurencinIndependent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 33.77k | 16.04% |
| 2026-05-21 | Dr. Cato T. LaurencinIndependent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 33.77k | - |
| 2026-05-21 | Dr. Richard Brian GaynorIndependent Director | -1.48k | 54.50k | Derivative Exercise and Sale | 36.95 | 35.75k | - |
| 2026-05-21 | Dr. Richard Brian GaynorIndependent Director | 4.67k | 0.00 | Derivative Exercise and Retained Stock | - | 35.75k | 15.01% |
| 2026-05-21 | Mr. Shane Martin CookeIndependent Director | 2.94k | 0.00 | Derivative Exercise and Retained Stock | - | 106.68k | 2.83% |
| 2026-05-21 | Mr. Shane Martin CookeIndependent Director | -3.21k | 118.50k | Derivative Exercise and Sale | 36.95 | 106.68k | - |
| 2026-05-04 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -2.03k | 67.53k | Automatic Disposition | 33.20 | 231.56k | -0.87% |
| 2026-05-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 70.28k | Derivative Exercise and Sale | 19.34 - 33.40 | 81.39k | - |
| 2026-05-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 133.58k | Automatic Disposition | 33.40 | 81.39k | -4.68% |
| 2026-04-11 | Ms. Nancy S. LurkerIndependent Director | 2.85k | 0.00 | Derivative Exercise and Retained Stock | - | 13.56k | 26.62% |
| 2026-04-11 | Ms. Nancy S. LurkerIndependent Director | -901.00 | 30.06k | Derivative Exercise and Sale | 33.36 | 13.56k | - |
| 2026-04-06 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -2.03k | 70.32k | Automatic Disposition | 34.57 | 233.59k | -0.86% |
| 2026-04-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 80.86k | Derivative Exercise and Sale | 19.34 - 35.51 | 85.39k | - |
| 2026-04-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 142.05k | Automatic Disposition | 35.51 | 85.39k | -4.47% |
| 2026-03-02 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -6.89k | 201.81k | Automatic Disposition | 29.29 | 7.72k | -47.17% |
| 2026-03-02 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -6.00k | 180.00k | Automatic Disposition | 30.00 | 109.77k | -5.18% |
| 2026-03-02 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -4.07k | 120.11k | Automatic Disposition | 29.29 - 29.76 | 235.63k | -1.70% |
| 2026-03-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 51.90k | Derivative Exercise and Sale | 19.34 - 29.72 | 89.39k | - |
| 2026-03-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 118.88k | Automatic Disposition | 29.72 | 89.39k | -4.28% |
| 2026-02-26 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | 1.94k | 0.00 | Derivative Exercise and Retained Stock | - | 14.61k | 15.31% |
| 2026-02-26 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -808.00 | 24.83k | Derivative Exercise and Sale | 30.73 | 14.61k | - |
| 2026-02-26 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | 3.01k | 0.00 | Derivative Exercise and Retained Stock | - | 115.77k | 2.67% |
| 2026-02-26 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -2.40k | 73.84k | Derivative Exercise and Sale | 30.73 | 115.77k | - |
| 2026-02-26 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | 4.63k | 0.00 | Derivative Exercise and Retained Stock | - | 241.31k | 1.95% |
| 2026-02-26 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -3.70k | 113.55k | Derivative Exercise and Sale | 30.73 | 241.31k | - |
| 2026-02-26 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | 3.82k | 0.00 | Derivative Exercise and Retained Stock | - | 93.39k | 4.26% |
| 2026-02-26 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -3.05k | 93.70k | Derivative Exercise and Sale | 30.73 | 93.39k | - |
| 2026-02-26 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 3.82k | 0.00 | Derivative Exercise and Retained Stock | - | 239.69k | 1.62% |
| 2026-02-26 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -3.05k | 93.70k | Derivative Exercise and Sale | 30.73 | 239.69k | - |
| 2026-02-23 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 12.67k | 14.57% |
| 2026-02-23 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -672.00 | 21.63k | Derivative Exercise and Sale | 32.19 | 12.67k | - |
| 2026-02-23 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | 3.56k | 0.00 | Derivative Exercise and Retained Stock | - | 112.76k | 3.26% |
| 2026-02-23 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -2.85k | 91.58k | Derivative Exercise and Sale | 32.19 | 112.76k | - |
| 2026-02-23 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | 4.86k | 0.00 | Derivative Exercise and Retained Stock | - | 236.68k | 2.10% |
| 2026-02-23 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -3.88k | 124.90k | Derivative Exercise and Sale | 32.19 | 236.68k | - |
| 2026-02-23 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | 4.28k | 0.00 | Derivative Exercise and Retained Stock | - | 89.57k | 5.01% |
| 2026-02-23 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -3.41k | 109.90k | Derivative Exercise and Sale | 32.19 | 89.57k | - |
| 2026-02-23 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 4.28k | 0.00 | Derivative Exercise and Retained Stock | - | 235.88k | 1.85% |
| 2026-02-23 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -3.41k | 109.90k | Derivative Exercise and Sale | 32.19 | 235.88k | - |
| 2026-02-18 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | 3.34k | 0.00 | Derivative Exercise and Retained Stock | - | 11.06k | 43.28% |
| 2026-02-18 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -1.69k | 53.93k | Derivative Exercise and Sale | 32.00 - 32.02 | 11.06k | - |
| 2026-02-18 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | 8.25k | 0.00 | Derivative Exercise and Retained Stock | - | 109.20k | 8.18% |
| 2026-02-18 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -4.15k | 132.71k | Derivative Exercise and Sale | 32.00 - 32.02 | 109.20k | - |
| 2026-02-18 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | 9.66k | 0.00 | Derivative Exercise and Retained Stock | - | 85.30k | 12.77% |
| 2026-02-18 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -6.91k | 221.22k | Derivative Exercise and Sale | 32.00 - 32.02 | 85.30k | - |
| 2026-02-18 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | 10.27k | 0.00 | Derivative Exercise and Retained Stock | - | 231.82k | 4.64% |
| 2026-02-18 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -7.93k | 253.71k | Derivative Exercise and Sale | 32.00 - 32.02 | 231.82k | - |
| 2026-02-18 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 8.50k | 0.00 | Derivative Exercise and Retained Stock | - | 231.60k | 3.81% |
| 2026-02-18 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -5.53k | 177.10k | Derivative Exercise and Sale | 32.00 - 32.02 | 231.60k | - |
| 2026-02-05 | Mr. Richard F. PopsChairman & CEO | -62.23k | 2.09M | Sale to Issuer | 33.55 | 1.38M | -4.32% |
| 2026-02-05 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -8.63k | 289.40k | Sale to Issuer | 33.55 | 221.55k | -3.75% |
| 2026-02-05 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -6.39k | 214.35k | Sale to Issuer | 33.55 | 100.95k | -5.95% |
| 2026-02-05 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -7.45k | 250.08k | Sale to Issuer | 33.55 | 75.64k | -8.97% |
| 2026-02-05 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -7.62k | 255.62k | Sale to Issuer | 33.55 | 223.11k | -3.30% |
| 2026-02-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 74.52k | Derivative Exercise and Sale | 19.34 - 34.24 | 57.74k | - |
| 2026-02-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 134.16k | Automatic Disposition | 33.54 | 57.74k | -6.48% |
| 2026-02-02 | Mr. Shane Martin CookeIndependent Director | -61.20k | 179.30k | Derivative Exercise and Sale | 31.64 - 34.78 | 103.74k | - |
| 2026-01-08 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 53.31k | Derivative Exercise and Sale | 19.34 - 30.00 | 61.74k | - |
| 2026-01-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 112.00k | Automatic Disposition | 28.00 | 61.74k | -6.08% |
| 2025-12-03 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -3.75k | 39.96k | Derivative Exercise and Sale | 19.34 - 30.00 | 65.74k | - |
| 2025-12-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 117.20k | Automatic Disposition | 29.30 | 65.74k | -5.74% |
| 2025-11-03 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 55.21k | Derivative Exercise and Sale | 19.34 - 30.38 | 69.74k | - |
| 2025-11-03 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 121.53k | Automatic Disposition | 30.38 | 69.74k | -5.42% |
| 2025-10-15 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5.00k | 60.95k | Derivative Exercise and Sale | 19.34 - 31.53 | 73.74k | - |
| 2025-10-15 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4.00k | 126.12k | Automatic Disposition | 31.53 | 73.74k | -5.15% |
| 2025-08-03 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 1.12k | 0.00 | Derivative Exercise and Retained Stock | - | 205.37k | 0.55% |
| 2025-08-03 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -895.00 | 23.76k | Derivative Exercise and Sale | 26.55 | 205.37k | - |
| 2025-06-09 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -6.67k | 210.14k | Automatic Disposition | 31.09 - 31.95 | 86.21k | -7.18% |
| 2025-06-08 | Dr. Christopher I. WrightIndependent Director | 2.51k | 0.00 | Derivative Exercise and Retained Stock | - | 23.01k | 12.23% |
| 2025-06-08 | Dr. Christopher I. WrightIndependent Director | -793.00 | 25.15k | Derivative Exercise and Sale | 31.71 | 23.01k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
